| Dr Adolph Ralph Yaniz, MD | |
|
5490 Broadway, Suite 105, Merrillville, IN 46410-1675 | |
| (219) 884-3210 | |
| (219) 884-3244 |
| Full Name | Dr Adolph Ralph Yaniz |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 5490 Broadway, Merrillville, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639229156 | NPI | - | NPPES |
| 000000088069 | Other | IN | BLUE CROSS BLUE SHIELD |
| 100201270A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 010380025A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adolph Ralph Yaniz, MD 5490 Broadway, Suite 105, Merrillville, IN 46410-1675 Ph: (219) 884-3210 | Dr Adolph Ralph Yaniz, MD 5490 Broadway, Suite 105, Merrillville, IN 46410-1675 Ph: (219) 884-3210 |
News Archive
Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar (sorafenib) tablets, Stivarga (regorafenib) tablets and the recently U.S. Food and Drug Administration approved product Xofigo (radium Ra 223 dichloride) injection will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31 – June 4, in Chicago, IL (USA).
An autoimmune side effect of immune checkpoint inhibitor (ICI) drugs could signal improved control of kidney cancer, according to a new study by researchers in UT Southwestern's Kidney Cancer Program (KCP).
The American College of Cardiology's National Cardiovascular Data Registry was the source of data for research published throughout 2016, including a study examining if atrial fibrillation patients are being prescribed oral anticoagulants, how appropriate use criteria correlates to angioplasty rates and the variation among racial groups for revascularization procedures.
In an effort to find ways to improve long-term outcomes for people with opioid use disorder, University of Massachusetts Amherst epidemiology researcher Elizabeth Evans set out to study the obstacles to treating this chronic condition with an effective medication, buprenorphine-naloxone.
Autism researchers at the University of Washington will take the initial step in attempting to prevent the developmental disorder when they launch an $11.3 million study this week.
› Verified 4 days ago
Johann David Farley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8300 Broadway Ste D2, Merrillville, IN 46410 Phone: 219-649-0044 Fax: 219-649-0055 | |
Dr. Brian H Weiss, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 West 80th Ave., Ste A, Merrillville, IN 46410 Phone: 219-791-9785 Fax: 219-791-9787 | |
Dr. Oranu G Ibekie, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1574 E 85th Ave, Merrillville, IN 46410 Phone: 219-769-4400 Fax: 219-795-1419 | |
Dr. Syed S Kazmi, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 616 W 81st Ave, Merrillville, IN 46410 Phone: 312-421-1016 | |
Fadi I Alzeidan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 7863 Broadway, Merrillville, IN 46410 Phone: 219-769-6639 Fax: 219-769-0636 | |
Jessica Jean Glinski, DNP, FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 5043 E 81st Ave, Merrillville, IN 46410 Phone: 219-707-5276 | |
Lauren Dandurand, AGACNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 200 E 89th Ave Ste 2a, Merrillville, IN 46410 Phone: 219-736-2800 |